Integrated causal inference, kidney transcriptomics, and experimental validation identify ChREBP (&lt;i&gt;MLXIPL&lt;/i&gt;) as a driver of maladaptive metabolic remodeling in diabetic kidney disease. This evidence concerns the gene MLXIPL and diabetic kidney disease.